Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Managing Pain and Comorbidities in HS Patients
Description
The discussion focuses on managing pain and comorbidities in patients with hidradenitis suppurativa (HS). Pain is highlighted as a significant concern, affecting the quality of life, even in patients undergoing medical treatment. Various types of pain, including nociceptive, neuropathic, and nociplastic pain, are described, emphasizing the need for a multimodal approach to pain management. First-line treatments such as acetaminophen and ibuprofen are suggested, along with considerations for using opioids when necessary, while ensuring a cautious prescription process due to the risks associated with opioid use. Mental health conditions, particularly depression and anxiety, are prevalent in HS patients, with suggestions for screening and referral to mental health services. The importance of addressing inflammatory bowel disease (IBD) and polycystic ovarian syndrome (PCOS) as common comorbidities in HS is also noted, with specific diagnostic and treatment strategies, including the use of TNF inhibitors for IBD. Additionally, the talk addresses wound care management, emphasizing non-adherent dressings and navigating insurance for coverage of necessary supplies. Overall, a comprehensive approach integrating pain management, mental health, and comorbidity management is essential for improving patient outcomes in HS.
View moreConclusions
- Pain is a significant contributor to the impairment of quality of life in patients with HS, necessitating effective pain management strategies.
- A multimodal approach, including disease-directed therapies and specific pain management options, is often required for HS patients.
- Different types of pain in HS patients include nociceptive, neuropathic, and nociplastic pain, each requiring distinct treatment approaches.
- Chronic pain management may utilize anticonvulsants, SNRIs, and low-dose naltrexone, tailored to the patient's specific pain type.
- There is a high prevalence of mental health comorbidities such as depression and anxiety in HS patients, with significant risks such as increased suicide rates.
- Screening for mental health issues should be incorporated into care for HS patients to facilitate early detection and treatment.
- Patients with HS should be assessed for inflammatory bowel disease (IBD) and possible polycystic ovarian syndrome (PCOS) due to overlapping risks and increased prevalence.
- Collaboration with GI specialists is necessary for managing HS patients with IBD to optimize treatment regimens and dosage.
- Lifestyle interventions, including diet modifications, are recommended for patients with both HS and IBD.
- Wound care management is essential in HS, involving the use of appropriate dressing types to alleviate pain and promote healing.
- Savage et al, JAAD, 2021
- Damas O. M., Syme G., Trakman G. L., Yao C. K., McKeever L., Lewis J. D. Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 2020;18:1381-1392.